Your browser doesn't support javascript.
loading
Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche.
Chiblak, Sara; Tang, Zili; Lemke, Dieter; Knoll, Maximilian; Dokic, Ivana; Warta, Rolf; Moustafa, Mahmoud; Mier, Walter; Brons, Stephan; Rapp, Carmen; Muschal, Stefan; Seidel, Philipp; Bendszus, Martin; Adeberg, Sebastian; Wiestler, Otmar D; Haberkorn, Uwe; Debus, Jürgen; Herold-Mende, Christel; Wick, Wolfgang; Abdollahi, Amir.
Afiliação
  • Chiblak S; German Cancer Consortium, Heidelberg, Germany.
  • Tang Z; Division of Molecular & Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology, Heidelberg University Medical School and National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Lemke D; German Cancer Consortium, Heidelberg, Germany.
  • Knoll M; Division of Molecular & Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology, Heidelberg University Medical School and National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Dokic I; German Cancer Consortium, Heidelberg, Germany.
  • Warta R; Department of Neurology, Heidelberg University Medical School and National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Moustafa M; German Cancer Consortium, Heidelberg, Germany.
  • Mier W; Division of Molecular & Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology, Heidelberg University Medical School and National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Brons S; German Cancer Consortium, Heidelberg, Germany.
  • Rapp C; Division of Molecular & Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology, Heidelberg University Medical School and National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Muschal S; German Cancer Consortium, Heidelberg, Germany.
  • Seidel P; Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg Medical School, Heidelberg, Germany.
  • Bendszus M; German Cancer Consortium, Heidelberg, Germany.
  • Adeberg S; Division of Molecular & Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology, Heidelberg University Medical School and National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Wiestler OD; German Cancer Consortium, Heidelberg, Germany.
  • Haberkorn U; Department of Nuclear Medicine, Heidelberg University Medical School and National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Debus J; Division of Molecular & Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology, Heidelberg University Medical School and National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Herold-Mende C; German Cancer Consortium, Heidelberg, Germany.
  • Wick W; Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg Medical School, Heidelberg, Germany.
  • Abdollahi A; German Cancer Consortium, Heidelberg, Germany.
JCI Insight ; 4(2)2019 Jan 24.
Article em En | MEDLINE | ID: mdl-30674721
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article